Real-world Effect of Monoclonal Antibody Treatment in COVID-19 Patients in a Diverse Population in the United States

Kaitlin Rainwater-Lovett, John T. Redd, Miles A. Stewart, Natalia Elías Calles, Tyler Cluff, Mike Fang, Mark J. Panaggio, Anastasia S. Lambrou, Jonathan K. Thornhill, Christopher Bradburne, Samuel Imbriale, Jeffrey D. Freeman, Michael Anderson, Robert Kadlec
doi: https://doi.org/10.1101/2021.04.08.21254705

Article usage

Article usage: April 2021 to November 2024

AbstractFullPdf
Apr 2021216831341
May 20215691150
Jun 20211721559
Jul 20211293367
Aug 202144918793
Sep 202137397231
Oct 202132682244
Nov 20212705529
Dec 2021902013
Jan 2022681313
Feb 20224198
Mar 20223934
Apr 202235312
May 202246713
Jun 202245198
Jul 202247373
Aug 20223329
Sep 202243510
Oct 20223618
Nov 20222473
Dec 202214113
Jan 202328414
Feb 20231987
Mar 20231253
Apr 20233437
May 20232017
Jun 2023747
Jul 20231018
Aug 202322107
Sep 20231153
Oct 2023942
Nov 2023331521
Dec 20233804
Jan 20248034
Feb 20241846
Mar 202465104
Apr 20243694
May 2024625
Jun 20241327
Jul 20241526
Aug 202419211
Sep 20242657
Oct 20241234
Nov 2024305
Back to top
Posted August 13, 2021.
Download PDF
Data/Code
Email
Real-world Effect of Monoclonal Antibody Treatment in COVID-19 Patients in a Diverse Population in the United States
Kaitlin Rainwater-Lovett, John T. Redd, Miles A. Stewart, Natalia Elías Calles, Tyler Cluff, Mike Fang, Mark J. Panaggio, Anastasia S. Lambrou, Jonathan K. Thornhill, Christopher Bradburne, Samuel Imbriale, Jeffrey D. Freeman, Michael Anderson, Robert Kadlec
medRxiv 2021.04.08.21254705; doi: https://doi.org/10.1101/2021.04.08.21254705
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area